Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Descubra as apostas de Malvino Salvador para manter a pele bonita e saudável


News provided by

Galderma

Jan 19, 2023, 08:52 ET

Share this article

Share toX

Share this article

Share toX

Ator elegeu o bioestimulador de colágeno Sculptra® e o preenchedor à base de ácido hialurônico Restylane®, ambos da Galderma, como tratamentos estéticos indispensáveis no cuidado com a sua pele

SÃO PAULO, 19 de janeiro de 2023 /PRNewswire/ -- Malvino Salvador é adepto ao autocuidado e está ligado às tendências de procedimentos estéticos que priorizam sua individualidade. O ator mantém uma rotina de hábitos saudáveis que vão desde alimentação balanceada até a prática regular de exercícios físicos que contribuem para o bem-estar do corpo e mente.

Continue Reading
Malvino Salvador
Malvino Salvador

Aos 46 anos, Malvino revela que é adepto dos tratamentos estéticos que, associados à sua rotina saudável, contribuem para recuperar a firmeza e a sustentação da pele¹, além de atenuar rugas e marcas de expressões, realçando seus traços individuais.

Um dos produtos indicados pela dermatologista do ator é o Sculptra®, um bioestimulador de colágeno que pode ser aplicado em algumas regiões da face¹ e diversas áreas do corpo². Com eficácia comprovada, o produto aumenta em até 66.5% a produção de colágeno tipo l da pele após três meses da primeira aplicação³, com duração de até 25 meses4, podendo variar de acordo com a história de cada pele.

"Foi o tempo em que as pessoas pensavam que autocuidado não era coisa de homem. Cuidar de si vai muito além da aparência e é por isso que eu faço uso de Sculptra® e Restylane®. Esses produtos melhoram a saúde da minha pele e me ajudam a conquistar um envelhecimento saudável e alto astral", conta Malvino.

A dermatologista de Malvino, Dra. Aline Vieira (CRM-RJ 739.545) explica que, "A aplicação do bioestimulador de colágeno gera uma reação no corpo que leva a pele a produzir mais colágeno. Pode ser feita em várias áreas do rosto e do corpo, como braços, pescoço, abdômen, glúteo, coxas e joelhos. O número de aplicações necessárias depende da necessidade individual de reposição de colágeno, por isso, há a necessidade de avaliação de um profissional de saúde habilitado. Mas, geralmente, é feito em três sessões5". 

Mas, a pele madura não sofre só com a perda de colágeno. Com o passar dos anos, a perda de gordura e estrutura óssea também contribuem para o aspecto de aparência cansada. Para atenuar estes efeitos, Restylane®, preenchedor à base de ácido hialurônico com 26 anos de uso no mercado de estética, também foi o escolhido pela dermatologista do ator.

"Eu queria amenizar algumas rugas e linhas de expressão, e definir o contorno do rosto. Aí minha médica sugeriu fazermos o preenchimento com Restylane® para, mesmo de forma sutil, conseguir evidenciar ainda mais o meu rosto", comenta Malvino.

A linha de preenchedores Restylane® é a mais completa do mercado6 e traz produtos que possibilitam tratamentos individualizados para acentuar contornos da face e amenizar aspectos de rugas. Soma-se ao portfólio os SkinboostersTM, também à base de ácido hialurônico, mas na composição de um gel ultrafino que oferece um verdadeiro boom na hidratação da pele de dentro para fora, recuperando o viço e a elasticidade e diminuindo o aspecto de linhas finas7. Restylane® SkinboostersTM pode ser aplicado na face, pescoço, colo e mãos. 

"Antes de recomendarmos o protocolo de tratamento de cada paciente, avaliamos o tipo de pele, a moldura da face e outros aspectos que, juntos, definem a beleza de cada paciente. Depois da avaliação individual do Malvino, vimos que o tratamento para estimular mais colágeno, associado à projeção do queixo, certamente iam contribuir para realçar os traços que já são dele. O ácido hialurônico é uma aplicação segura por sua alta biocompatibilidade e, sem dúvida, ter um leque amplo de opções em termos de composição de géis nos ajuda a oferecer tratamentos personalizados, mantendo os aspectos naturais que compõem a beleza de cada um", explica Dra. Aline.   

A dermatologista ainda esclarece que, ambos os procedimentos quando usados de forma regular e com a ajuda de um profissional de saúde habilitado, ajudam a recuperar essas perdas de modo a manter a qualidade de pele independentemente da idade. A profissional também ressalta que para a maioria das pessoas, estes procedimentos são pouco doloridos. 

Diante de soluções estéticas de alta eficácia, Malvino Salvador conclui: "Acredito e uso os procedimentos estéticos com foco em manter a qualidade da minha pele no longo prazo. Cada vez mais temos soluções que nos ajudam a avançar na idade mantendo a qualidade de vida e o aspecto saudável. Depois que conheci Sculptra® e Restylane® não fico mais sem". 

Sculptra® e Restylane® são produtos utilizados em procedimentos estéticos pouco invasivos que devem ser realizados por profissionais de saúde habilitados à prática de procedimentos estéticos injetáveis.

¹Machado Filho CDS, Santos TC, Rodrigues APLJ, da Cunha MG. Ácido poli-L-láctico: um agente bioestimulador. Surg Cosmet Dermatol. 2013;5(4):345-50.

²Haddad A, Menezes A, Guarnieri C, et al. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas. J Drugs Dermatol. 2019;18(9):929-935.

³Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-922.

4Narins R, Baumann L, Brandt F et al. A randomized study of the efficacy and safety of Injectable poly-l-lactic acid versus human–based collagen implant in the treatment. J Am Acad Dermatol. 2010 Mar;62(3):448-62

5Vleggaar D, et al. Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volumization. Journal of Drugs in Dermatology 2014; 13(4): S44-55.

6Rzany B., Bayerl C., Bodokh I. et al. Eficacy and safety of a new hyaluronic acid dermal  filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011;13:107-112

7Streker M et al. Stabilized hyaluronic acid-based gel oh non-animal origin for skin rejuvenation: face, hand and décolletage.J Drugs Dermatol. 2013; 12(9):990-4

Sobre a Galderma

A Galderma é a maior empresa independente de dermatologia do mundo, presente em aproximadamente 90 países. Desde a sua criação em 1981, tem sido movida por uma dedicação completa à Dermatologia, oferecendo um portfólio inovador e com base científica de marcas e serviços sofisticados em Estética, Produtos ao Consumidor e Medicamentos. Focada nas necessidades dos consumidores e pacientes, a Galderma trabalha em parceria com profissionais de saúde para garantir resultados superiores. As marcas de estética da Galderma foram consideradas, pelo segundo ano consecutivo, top of mind dos profissionais da saúde nas categorias Bioestimuladores de Colágeno e Ácido Hialurônico, segundo pesquisa realizada em 2022. A empresa segue avançando a dermatologia para cada história de pele, porque entende que a pele em que estamos molda nossas histórias de vida. Para  mais informações, visite https://www.galdermaaesthetics.com.br/

Foto - https://mma.prnewswire.com/media/1986722/Picture1.jpg

FONTE Galderma

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.